American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn) (American Psychiatric Publishing, 2013).
Shaw, K. A. et al. Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years—autism and developmental disabilities monitoring network, 16 sites, United States, 2022. MMWR Surveill. Summ. 74, 1–22 (2025).
McBain, R. K., Kareddy, V., Cantor, J. H., Stein, B. D. & Yu, H. Systematic review: United States workforce for autism-related child healthcare services RH = US health workforce for autism care: a review. J. Am. Acad. Child Adolesc. Psychiatry 59, 113–139 (2020).
Matson, J. L. et al. Examining cross-cultural differences in autism spectrum disorder: a multinational comparison from Greece, Italy, Japan, Poland, and the United States. Eur. Psychiatry 42, 70–76 (2017).
Lord, C. et al. Autism Diagnostic Observation Schedule—2nd Edition (ADOS-2) 284, 474–478 (Western Psychological Corporation, 2012).
Yu, Q., Li, E., Li, L. & Liang, W. Efficacy of interventions based on applied behavior analysis for autism spectrum disorder: a meta-analysis. Psychiatry Investig. 17, 432–443 (2020).
Kose, L. K., Fox, L. & Storch, E. A. Effectiveness of cognitive behavioral therapy for individuals with autism spectrum disorders and comorbid obsessive-compulsive disorder: a review of the research. J. Dev. Phys. Disabil. 30, 69–87 (2018).
Nejati, V., Peyvandi, A., Nazari, N. & Abadi, F. The effectiveness of social training in individuals with autism spectrum disorder (ASD): a systematic review and transfer analysis. Sci. Rep. 14, 32131 (2024).
Gazerani, P. The neuroplastic brain: current breakthroughs and emerging frontiers. Brain Res. 1858, 149643 (2025).
Salazar de Pablo, G. et al. Systematic review and meta-analysis: efficacy of pharmacological interventions for irritability and emotional dysregulation in autism spectrum disorder and predictors of response. J. Am. Acad. Child Adolesc. Psychiatry 62, 151–168 (2023).
Demetriou, E. A. et al. Autism spectrum disorders: a meta-analysis of executive function. Mol. Psychiatry 23, 1198–1204 (2018).
Eckes, T., Buhlmann, U., Holling, H.-D. & Möllmann, A. Comprehensive ABA-based interventions in the treatment of children with autism spectrum disorder—a meta-analysis. BMC Psychiatry 23, 133 (2023).
Sandbank, M. et al. Project AIM: autism intervention meta-analysis for studies of young children. Psychol. Bull. 146, 1–29 (2020).
Manter, M. A. et al. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Med. 23, 11 (2025).
Feroe, A. G. et al. Medication use in the management of comorbidities among individuals with autism spectrum disorder from a large nationwide insurance database. JAMA Pediatr. 175, 957–965 (2021).
Davico, C., Secci, I., Vendrametto, V. & Vitiello, B. Pharmacological treatments in autism spectrum disorder: a narrative review. J. Psychopathol. 29, 38–52 (2023).
Meza, N. et al. Non-pharmacological interventions for autism spectrum disorder in children: an overview of systematic reviews. BMJ Evid. Based Med. 28, 273–282 (2023).
Lee, J. D., Kang, V. Y., Terol, A. K. & Joo, S. Examining the efficacy of culturally responsive interventions for autistic children and their families: a meta-analysis. J. Autism Dev. Disord. 55, 706–726 (2025).
Siafis, S. et al. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol. Autism 13, 10 (2022).
Lewis, A. S. & van Schalkwyk, G. I. Systematic review: distribution of age and intervention modalities in therapeutic clinical trials for autism spectrum disorder. J. Autism Dev. Disord. 50, 2208–2216 (2020).
van ‘t Hof, M. et al. Age at autism spectrum disorder diagnosis: a systematic review and meta-analysis from 2012 to 2019. Autism 25, 862–873 (2021).
Standard Country or Area Codes for Statistical Use (M49) (United Nations Statistics Division, 2023); https://unstats.un.org/unsd/methodology/m49
Linstead, E. et al. An evaluation of the effects of intensity and duration on outcomes across treatment domains for children with autism spectrum disorder. Transl. Psychiatry 7, e1234 (2017).
Totton, N., Lin, J., Julious, S., Chowdhury, M. & Brand, A. A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020. Pilot Feasibility Stud. 9, 188 (2023).
Spreckley, M. & Boyd, R. Efficacy of applied behavioral intervention in preschool children with autism for improving cognitive, language, and adaptive behavior: a systematic review and meta-analysis. J. Pediatr. 154, 338–344 (2009).
Reichow, B., Hume, K., Barton, E. E. & Boyd, B. A. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst. Rev. 5, CD009260 (2018).
Wong, C. et al. Evidence-based practices for children, youth, and young adults with autism spectrum disorder: a comprehensive review. J. Autism Dev. Disord. 45, 1951–1966 (2015).
LeClerc, S. & Easley, D. Pharmacological therapies for autism spectrum disorder: a review. P T 40, 389–397 (2015).
Cuijpers, P., Li, J., Hofmann, S. G. & Andersson, G. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clin. Psychol. Rev. 30, 768–778 (2010).
Sher, M. A. & Oliver, C. Assessment of self-report response bias in high functioning autistic people. Psychiatry Psychol. Law 30, 229–248 (2022).
Albaum, C. S., Sellitto, T., Vashi, N., Bohr, Y. & Weiss, J. A. Treatment engagement as a predictor of therapy outcome following cognitive behaviour therapy for autistic children. J. Autism Dev. Disord. 54, 3575–3586 (2024).
de Leeuw, A., Happé, F. & Hoekstra, R. A. A conceptual framework for understanding the cultural and contextual factors on autism across the globe. Autism Res. 13, 1029–1050 (2020).
Carruthers, S. et al. A cross-cultural study of autistic traits across India, Japan and the UK. Mol. Autism 9, 52 (2018).
Hagan, A. T. et al. Oxytocin modulation of resting-state functional connectivity network topology in individuals with higher autistic traits. Psychoradiology 5, kkaf021 (2025).
Chatham, C. H. et al. Adaptive behavior in autism: minimal clinically important differences on the Vineland-II. Autism Res. 11, 270–283 (2018).
Cohen, J. Statistical Power Analysis for the Behavioral Sciences 2nd edn (Routledge, 1988).
Cuijpers, P. et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can. J. Psychiatry 58, 376–385 (2013).
Parsons, D., Cordier, R., Lee, H., Falkmer, T. & Vaz, S. A randomised controlled trial of an information communication technology delivered intervention for children with autism spectrum disorder living in regional Australia. J. Autism Dev. Disord. 49, 569–581 (2019).
Zhang, B. et al. Effectiveness of peer-mediated intervention on social skills for children with autism spectrum disorder: a randomized controlled trial. Transl. Pediatr. https://doi.org/10.21037/tp-22-110 (2022).
Fung, L. K. et al. Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 137, S124–S135 (2016).
Doyle, C. A. & McDougle, C. J. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin. Neurosci. 14, 263–279 (2012).
Delli, C. K. S., Polychronopoulou, S. A., Kolaitis, G. A. & Antoniou, A.-S. G. Review of interventions for the management of anxiety symptoms in children with ASD. Neurosci. Biobehav. Rev. 95, 449–463 (2018).
Wampold, B. E. How important are the common factors in psychotherapy? An update. World Psychiatry 14, 270–277 (2015).
Yuan, L.-X. et al. A systematic review of transcranial magnetic stimulation treatment for autism spectrum disorder. Heliyon 10, e32251 (2024).
Ghafghazi, S., Carnett, A., Neely, L., Das, A. & Rad, P. AI-augmented behavior analysis for children with developmental disabilities: building toward precision treatment. IEEE Syst. Man Cybern. Mag. 7, 4–12 (2021).
Atturu, H. & Naraganti, S. Effectiveness of AI-driven individualized learning approach for children with autism spectrum disorder (ASD). Eur. Psychiatry 67, S77 (2024).
Yu, Y., Ozonoff, S. & Miller, M. Assessment of autism spectrum disorder. Assessment 31, 24–41 (2024).
Hong, C. et al. Testing small study effects in multivariate meta-analysis. Biometrics 76, 1240–1250 (2020).
Zhang, L. et al. A follow-up study on the long-term effects of rehabilitation in children with autism spectrum disorders. NeuroRehabilitation 44, 1–7 (2019).
Steinhausen, H. C., Mohr Jensen, C. & Lauritsen, M. B. A systematic review and meta-analysis of the long-term overall outcome of autism spectrum disorders in adolescence and adulthood. Acta Psychiatr. Scand. 133, 445–452 (2016).
Higgins, J. P. T., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557–560 (2003).
Hedges, L. V. & Olkin, I. in Statistical Methods for Meta-Analysis (eds Hedges, L. V. & Olkin, I.) Ch. 9, 189–203 (Academic Press, 1985).
DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177–188 (1986).
Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997).
Duval, S. & Tweedie, R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455–463 (2000).
R Core Team R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2023).
Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36, 1–48 (2010).
Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898 (2019).
Cochran, W. G. The combination of estimates from different experiments. Biometrics 10, 101–129 (1954).
McGuinness, L. A. & Higgins, J. P. T. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res. Synth. Methods 12, 55–61 (2021).
Gu, Y., Fox, M. & Zhao, D. R code and data for a systematic review and meta-analysis of pharmacological and nonpharmacological interventions for autism spectrum disorder. Zenodo https://doi.org/10.5281/zenodo.19369463 (2026).
Leave a Reply